Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
News articleYahoo Finance· March 10, 2026
Catalyst Pharmaceuticals: Exceptional Fundamentals Trading at 20-33% Discount
View original at finance.yahoo.comCatalyst Pharmaceuticals: Exceptional Fundamentals Trading at 20-33% Discount This article first appeared on GuruFocus. Introduction: At $24.50, what you're really getting with Catalyst Pharmaceuticals Inc…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
Hetero litigation expected to conclude sometime in 2026
80% confidenceFIRDAPSE patent protection extends through February 2035
80% confidenceEstimated 3,000-4,000 US patients with Lambert-Eaton Myasthenic Syndrome
80% confidenceThere are approximately 15,000 patients in the US with Duchenne Muscular Dystrophy
80% confidenceCurrent R&D spending is about 5-8% of revenue
80% confidence
